Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  Holst, Charles R ^a   Bou Reslan, Hani ^a   Gore, Bryan B ^a,b   Wong, Karen ^a   Grant, Deanna ^a   Chalasani, Sreedevi ^a   Carano, Richard A ^a   Frantz, Gretchen D ^a   Tessier Lavigne, Marc ^a   Bolon, Brad ^c   French, Dorothy M ^a   Ashkenazi, Avi ^a  

^a GENENTECH INC   (United States)

^b STANFORD UNIVERSITY   (United States)

^c GEMpath Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MORPHOGEN; POLYSACCHARIDE; PROTEOHEPARAN SULFATE; SULFATASE; SULFOTRANSFERASE; SULF1 PROTEIN, MOUSE; SULF2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BONE DEFECT; CELL SURFACE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME DEFICIENCY; ENZYME MODIFICATION; ENZYME RELEASE; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; FETAL WELL BEING; GENOTYPE; IN SITU HYBRIDIZATION; KIDNEY MALFORMATION; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NEWBORN; NEWBORN DEATH; NEWBORN MORTALITY; NONHUMAN; PHENOTYPE; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SULFATION; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; CELL CULTURE; CONGENITAL MALFORMATION; CYTOLOGY; FEMALE; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; KIDNEY; LETHAL GENE; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SURVIVAL RATE;

MUS;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; FIBROBLASTS; GENES, LETHAL; HEPARAN SULFATE PROTEOGLYCANS; IN SITU HYBRIDIZATION; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; PREGNANCY; SIGNAL TRANSDUCTION; SULFATASES; SULFOTRANSFERASES; SURVIVAL RATE;

EID: 39349106510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000575     Document Type: Article

References (46)

1. Hacker U, Nybakken K, Perrimon N (2005) Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 6: 530-541.
2. Perrimon N, Bernfeld M (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404: 725-728.
3. Lind T, Tufaro F, McCormick C, Lindahl U, Lidholt K (1998) The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate. J Biol Chem 273: 26265-26268.
4. McCormick C, Leduc Y, Martindale D, Mattison K, Esford LE, et al. (1998) The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate. Nat Genet 19: 158-161.
5. Esko JD, Selleck SB (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem 71: 435-471.
6. Forsberg E, Kjellen L (2001) Heparan sulfate: lessons from knockout mice. J Clin Invest 108: 175-180.
7. Ledin J, Staatz W, Li JP, Gotte M, Selleck S, et al. (2004) Heparan sulfate structure in mice with genetically modified heparan sulfate production. J Biol Chem 279: 42732-42741.
8. Lin X, Wei G, Shi Z, Dryer L, Esko JD, et al. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224: 299-311.
9. Bullock SL, Fletcher JM, Beddington RS, Wilson VA (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 12: 1894-1906.
10. Fan G, Xiao L, Cheng L, Wang X, Sun B, et al. (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467: 7-11.
11. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, et al. (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 275: 25926-25930.
12. Bink RJ, Habuchi H, Lele Z, Dolk E, Joore J, et al. (2003) Heparan sulfate 6-O-sulfotransferase is essential for muscle development in zebrafish. J Biol Chem 278: 31118-31127.
13. Chen E, Stringer SE, Rusch MA, Selleck SB, Ekker SC (2005) A unique role for 6-O sulfation modification in zebrafish vascular development. Dev Biol 284: 364-376.
14. Dhoot GY, Gustafsson MK, Ai X, Sun W, Standiford DM, et al. (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293: 1663-1666.
15. Morimoto-Tomita M, Uchimura Y, Werb Z, Hemmerich S, Rosen SD (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277: 49175-49185.
16. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, et al. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162: 341-351.
17. Lamanna WC, Baldwin RJ, Padva, M, Kalus I, Ten Dam G, et al. (2006) Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional cooperativity. Biochem J 400: 63-73.
18. Lamanna WC, Kalus J, Padva M, Baldwin RJ, Merry CL, et al. (2007) The heparanome-the enigma of encoding and decoding heparan sulfate sulfation. J Biotechnol 129: 290-307.
19. Lum DH, Tan J, Rosen SD, Werb Z (2007) Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol Cell Biol 27: 678-688.
20. Zambrowicz BP, Friedrich GA, Buxton EC, Lilleberg SI, Person C, et al. (1998) Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392: 608-611.
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Solloway MJ, Dudley AT, Bikoff EK, Lyons KM, Hogan BL, et al. (1998) Mice lacking Bmp6 function. Dev Genet 22: 321-339.
23. Lai J, Chien J, Staub J, Avula R, Greene EL, et al. (2003) Loss of HSulf-1 upregulates heparin-binding growth factor signaling in cancer. J Biol Chem 278: 23107-23117.
24. Ohto T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, et al. (2002) Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells 7: 173-185.
25. So AI, Wiltshire T, Batalov S, Lapp H, Ching KA, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101: 6062-6067.
26. Nagamine S, Koike S, Keino-Masu K, Masu M (2005) Expression of a heparan sulfate remodeling enzyme, heparan sulfate 6-O-endosulfatase sulfatase FP2, in the rat nervous system. Brain Res Dev. Brain Res 159: 135-143.
27. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271: 1116-1120.
28. Pellegrini L, Burke DF, von Delft F, Mulloy B, Blundell TL (2000) Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature 407: 1029-1034.
29. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, et al. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerizanon. Mol Cell 6: 743-750.
30. Hajihosseini MK, Lalioti MD, Arthaud S, Burgar HR, Brown JM, et al. (2004) Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131: 325-335.
31. Wang Q, Green RP, Zhao G, Ornitz DM (2001) Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development 128: 3867-3876.
32. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, et al. (1997) A lipid-anchored Grb2 binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693-702.
33. Katagiri T, Boorla S, Frendo JL, Hogan BL, Karsenty G (1998) Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. Dev Genet 22: 340-348.
34. Compagni A, Logan M, Klein R, Adams RH (2003) Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell 5: 217-230.
35. Jena N, Martin-Seisdedos C, McCue P, Croce CM (1997) BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 230: 28-37.
36. Cole F, Krauss RS (2003) Microform holoprosencephaly in mice that lack the Ig superfamily member Cdon. Curr Biol 13: 411-415.
37. Yagi T, Aizawa S, Tokunaga T, Shigetani Y, Takeda N, et al. (1993) A role for Fyn tyrosine kinase in the suckling behaviour of neonatal mice. Nature 366: 742-745.
38. DeChiara TM, Vejsada P, Poueymirou WT, Acheson A, Suri C, et al. (1995) Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83: 313-322.
39. Kamimura K, Koyama T, Habuchi H, Ueda R, Masu M, et al. (2006) Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol 174: 773-778.
40. Merry CL, Bullock SL, Swan DC, Backen AC, Lyon M, et al. (2001) The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. J Biol Chem 276: 35429-35434.
41. McLaughlin D, Karlsson F, Tian N, Pratt T, Bullock SL, et al. (2003) Specific modification of heparan sulphate is required for normal cerebral cortical development. Mech Dev 120: 1481-1488.
42. Lai JP, Chien J, Strome SE, Staub J, Montoya DP, et al. (2004) HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23: 1439-1447.
43. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, et al. (2004) hSulfl Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 126: 231-248.
44. Viviano BL, Paine-Saunders S, Gasiunas N, Gallagher J, Saunders S (2004) Domain-specific modification of heparan sulfate by Qsulfl modulates the binding of the bone morphogenetic protein antagonist Noggin. J Biol Chem 279: 5604-5611.
45. Wang S, Ai X, Freeman SD, Pownall ME, Lu Q et al. (2004) QSulfl, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci U S A 101: 4833-4838.
46. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, et al. (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem 7:2.